These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 451364)

  • 1. Influence on the depth of inhalation on the effect of the beta 2-receptor-stimulating drug fenoterol hydrobromide (berotec).
    Vanderschueren RG; Laros CD; Swierenga J
    Respiration; 1979; 37(6):318-27. PubMed ID: 451364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerosol administration of fenoterol hydrobromide (Th 1165a) in subjects with reversible obstructive airway disease.
    Pennock BE; Rogers RM; Ryan BR; Ayers LN
    Chest; 1977 Dec; 72(6):731-6. PubMed ID: 336306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouth spraying versus inhalation of fenoterol aerosol in healthy subjects and asthmatic patients.
    Rodenstein D; Stănescu DC
    Br J Dis Chest; 1982 Oct; 76(4):365-73. PubMed ID: 7150496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the bronchodilating action and of the tolerance of fenoterol and isoproterenol aerosols.
    Sasaki T; Sasaki H; Sugiyama M; Nakamura M; Takishima T
    Rev Inst Hyg Mines (Hasselt); 1979; 34(3):124-33. PubMed ID: 552657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal inhalation procedure for the fenoterol powder inhaler.
    Groth S; Dirksen H
    Eur J Respir Dis Suppl; 1983; 130():17-24. PubMed ID: 6581057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of asthmatic patients to fenoterol inhalation: a method of quantifying the airway bronchodilator dose.
    Ruffin RE; Kenworthy MC; Newhouse MT
    Clin Pharmacol Ther; 1978 Mar; 23(3):338-45. PubMed ID: 342174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the bronchodilator effects of oral therapy with fenoterol hydrobromide and ephedrine.
    Steen SN; Smith R; Kuo J; Ziment I; Beall G
    Chest; 1977 Sep; 72(3):291-5. PubMed ID: 891280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three month study of the bronchodilator effects of aerosolized fenoterol and isoproterenol.
    Beall GN; Steen SN; Kuo J; Smith R
    Chest; 1978 Jun; 73(6 Suppl):996-7. PubMed ID: 354893
    [No Abstract]   [Full Text] [Related]  

  • 9. Fenoterol inhalation powder as an alternative to treatment with the metered dose inhaler.
    Dirksen H; Groth S
    Eur J Respir Dis Suppl; 1983; 130():48-53. PubMed ID: 6581062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The oral application of berotec in the therapy of obstructive airway diseases].
    Veres R
    Fortschr Med; 1978 Mar; 96(10):553-7. PubMed ID: 631690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bronchodilator effect of fenoterol (Berotec).
    Powles AC
    N Z Med J; 1975 Mar; 81(535):249-51. PubMed ID: 1055321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fenoterol, ipratropium bromide and their combination in the therapy of bronchospasm].
    Petraglia A; Cecere L; Scarpitta M; Funaro G; Siano V
    Clin Ter; 1983 Mar; 104(5):395-401. PubMed ID: 6221858
    [No Abstract]   [Full Text] [Related]  

  • 13. Fenoterol powder inhaler technique in children: influence of inspiratory flow rate and breath-holding.
    Pedersen S; Steffensen G
    Eur J Respir Dis; 1986 Mar; 68(3):207-14. PubMed ID: 3699121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
    Morr H; Nink M; Ferlinz R
    Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the bronchodilator effect of oral fenoterol and ephedrine in asthmatic children.
    McLaughlin ET; Bethea LH; Wittig HJ
    Ann Allergy; 1982 Oct; 49(4):191-5. PubMed ID: 7125306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-selectivity of fenoterol. Comparison of intravenous and aerosol administration.
    Dürr MH; Baillie P
    S Afr Med J; 1975 Aug; 49(37):1517-8. PubMed ID: 1162529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between aerosol and inhaled powder administration of fenoterol in adult asthmatics.
    Harris R; Rothwell RP
    N Z Med J; 1981 Dec; 94(697):421-2. PubMed ID: 7038565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response and asthmatic patients to inhaled fenoterol.
    Ruffin RE; Kenworthy MC; Newhouse MT
    Chest; 1978 Jun; 73(6 Suppl):990-1. PubMed ID: 354891
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of beta 2-agonists (in the light of fenoterol).
    Schmidt EW; Ulmer WT; Rominger KL
    Respiration; 1995; 62(4):190-200. PubMed ID: 8578014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological effects and determination of the morphological distribution of powder aerosols containing fenoterol hydrobromide and ipratropium bromide.
    Traunecker W; Muacevic G; Tilov T
    Respiration; 1984; 45(3):271-5. PubMed ID: 6235560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.